ABBV vs HWKN · P/E 81, rev $16.99B vs P/E 40, rev $1.08B
AbbVie Inc (ABBV) versus Hawkins Inc (HWKN) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Hawkins Inc (HWKN) is a specialty chemicals company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported HWKN revenue for 2026-03-29 was $1.08B. Net income was $81.5M. Revenue was up 11.2% from 2025-03-30 to 2026-03-29. HWKN currently screens at market cap $3.24B and trailing P/E 39.7.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. HWKN currently screens at market cap $3.24B and trailing P/E 39.7.
Not investment advice. Open the ABBV and HWKN stock pages for the full models.
Not investment advice.